These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33066680)

  • 21. Comprehensive quality by design approach for stable nanocrystalline drug products.
    Jog R; Burgess DJ
    Int J Pharm; 2019 Jun; 564():426-460. PubMed ID: 31026489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods.
    Tian Y; Wang S; Yu Y; Sun W; Fan R; Shi J; Gu W; Wang Z; Zhang H; Zheng A
    Int J Pharm; 2022 Jul; 623():121862. PubMed ID: 35671851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
    Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
    Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of Top-down and Bottom-up Approaches by Using Design of Experiment (DoE) to Produce Meloxicam Nanocrystal Capsules.
    Liu T; Yu X; Yin H
    AAPS PharmSciTech; 2020 Jan; 21(3):79. PubMed ID: 31974817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
    Ghosh I; Schenck D; Bose S; Ruegger C
    Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation Nanocrystals of Poorly Soluble Plant Compounds Using an Ultra-Small-Scale Approach.
    Liu T; Yao G; Liu X; Yin H
    AAPS PharmSciTech; 2017 Oct; 18(7):2610-2617. PubMed ID: 28243886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
    Kumar S; Xu X; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
    Bilgili E; Li M; Afolabi A
    Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.
    Figueroa CE; Bose S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1046-55. PubMed ID: 23916460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology--a QbD perspective.
    Ghosh I; Schenck D; Bose S; Liu F; Motto M
    Pharm Dev Technol; 2013; 18(3):719-29. PubMed ID: 23061898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Formulation Parameters on Redispersibility of Naproxen Nanoparticles from Granules Produced in a Fluidized Bed Process.
    Wewers M; Czyz S; Finke JH; John E; Van Eerdenbrugh B; Juhnke M; Bunjes H; Kwade A
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32316108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
    George M; Ghosh I
    Eur J Pharm Sci; 2013 Jan; 48(1-2):142-52. PubMed ID: 23085547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions.
    Oktay AN; Ilbasmis-Tamer S; Celebi N
    Pharm Dev Technol; 2019 Dec; 24(10):1278-1286. PubMed ID: 31535942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring space-energy matching via quantum-molecular mechanics modeling and breakage dynamics-energy dissipation via microhydrodynamic modeling to improve the screening efficiency of nanosuspension prepared by wet media milling.
    Tian J; Qiao F; Hou Y; Tian B; Yang J
    Expert Opin Drug Deliv; 2021 Nov; 18(11):1643-1657. PubMed ID: 34382869
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method.
    Li F; Li L; Wang S; Yang Y; Li J; Liu D; Zhang S; Wang S; Xu H
    Asian J Pharm Sci; 2019 Nov; 14(6):649-657. PubMed ID: 32104491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
    Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
    Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.